The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Silodosin Market Research Report 2025
Synopsis
The global Oral Silodosin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral Silodosin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Silodosin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oral Silodosin include Daiichi Sankyo, Lupin Pharmaceuticals, Aurobindo Pharma, Recordati, Shanghai Huilun Pharmaceutical, Hainan Wanwei Pharmaceutical and Kunming Jida Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Silodosin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Silodosin.
Report Scope
The Oral Silodosin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Silodosin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Silodosin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Daiichi Sankyo
Lupin Pharmaceuticals
Aurobindo Pharma
Recordati
Shanghai Huilun Pharmaceutical
Hainan Wanwei Pharmaceutical
Kunming Jida Pharmaceutical
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospital and Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Silodosin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Silodosin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Oral Silodosin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral Silodosin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Silodosin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oral Silodosin include Daiichi Sankyo, Lupin Pharmaceuticals, Aurobindo Pharma, Recordati, Shanghai Huilun Pharmaceutical, Hainan Wanwei Pharmaceutical and Kunming Jida Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Silodosin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Silodosin.
Report Scope
The Oral Silodosin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Silodosin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Silodosin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Daiichi Sankyo
Lupin Pharmaceuticals
Aurobindo Pharma
Recordati
Shanghai Huilun Pharmaceutical
Hainan Wanwei Pharmaceutical
Kunming Jida Pharmaceutical
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospital and Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Silodosin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Silodosin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Silodosin Market Overview
1.1 Product Overview and Scope of Oral Silodosin
1.2 Oral Silodosin Segment by Type
1.2.1 Global Oral Silodosin Market Value Comparison by Type (2024-2030)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Oral Silodosin Segment by Application
1.3.1 Global Oral Silodosin Market Value by Application: (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.4 Global Oral Silodosin Market Size Estimates and Forecasts
1.4.1 Global Oral Silodosin Revenue 2019-2030
1.4.2 Global Oral Silodosin Sales 2019-2030
1.4.3 Global Oral Silodosin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Silodosin Market Competition by Manufacturers
2.1 Global Oral Silodosin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Silodosin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Silodosin Average Price by Manufacturers (2019-2024)
2.4 Global Oral Silodosin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Silodosin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Silodosin, Product Type & Application
2.7 Oral Silodosin Market Competitive Situation and Trends
2.7.1 Oral Silodosin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Silodosin Players Market Share by Revenue
2.7.3 Global Oral Silodosin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Silodosin Retrospective Market Scenario by Region
3.1 Global Oral Silodosin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Silodosin Global Oral Silodosin Sales by Region: 2019-2030
3.2.1 Global Oral Silodosin Sales by Region: 2019-2024
3.2.2 Global Oral Silodosin Sales by Region: 2025-2030
3.3 Global Oral Silodosin Global Oral Silodosin Revenue by Region: 2019-2030
3.3.1 Global Oral Silodosin Revenue by Region: 2019-2024
3.3.2 Global Oral Silodosin Revenue by Region: 2025-2030
3.4 North America Oral Silodosin Market Facts & Figures by Country
3.4.1 North America Oral Silodosin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Silodosin Sales by Country (2019-2030)
3.4.3 North America Oral Silodosin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Silodosin Market Facts & Figures by Country
3.5.1 Europe Oral Silodosin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Silodosin Sales by Country (2019-2030)
3.5.3 Europe Oral Silodosin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Oral Silodosin Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Silodosin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Silodosin Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Silodosin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Oral Silodosin Market Facts & Figures by Country
3.7.1 Latin America Oral Silodosin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Silodosin Sales by Country (2019-2030)
3.7.3 Latin America Oral Silodosin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oral Silodosin Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Silodosin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Silodosin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Silodosin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Silodosin Sales by Type (2019-2030)
4.1.1 Global Oral Silodosin Sales by Type (2019-2024)
4.1.2 Global Oral Silodosin Sales by Type (2025-2030)
4.1.3 Global Oral Silodosin Sales Market Share by Type (2019-2030)
4.2 Global Oral Silodosin Revenue by Type (2019-2030)
4.2.1 Global Oral Silodosin Revenue by Type (2019-2024)
4.2.2 Global Oral Silodosin Revenue by Type (2025-2030)
4.2.3 Global Oral Silodosin Revenue Market Share by Type (2019-2030)
4.3 Global Oral Silodosin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Silodosin Sales by Application (2019-2030)
5.1.1 Global Oral Silodosin Sales by Application (2019-2024)
5.1.2 Global Oral Silodosin Sales by Application (2025-2030)
5.1.3 Global Oral Silodosin Sales Market Share by Application (2019-2030)
5.2 Global Oral Silodosin Revenue by Application (2019-2030)
5.2.1 Global Oral Silodosin Revenue by Application (2019-2024)
5.2.2 Global Oral Silodosin Revenue by Application (2025-2030)
5.2.3 Global Oral Silodosin Revenue Market Share by Application (2019-2030)
5.3 Global Oral Silodosin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Daiichi Sankyo
6.1.1 Daiichi Sankyo Corporation Information
6.1.2 Daiichi Sankyo Description and Business Overview
6.1.3 Daiichi Sankyo Oral Silodosin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Daiichi Sankyo Oral Silodosin Product Portfolio
6.1.5 Daiichi Sankyo Recent Developments/Updates
6.2 Lupin Pharmaceuticals
6.2.1 Lupin Pharmaceuticals Corporation Information
6.2.2 Lupin Pharmaceuticals Description and Business Overview
6.2.3 Lupin Pharmaceuticals Oral Silodosin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Lupin Pharmaceuticals Oral Silodosin Product Portfolio
6.2.5 Lupin Pharmaceuticals Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Oral Silodosin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aurobindo Pharma Oral Silodosin Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Recordati
6.4.1 Recordati Corporation Information
6.4.2 Recordati Description and Business Overview
6.4.3 Recordati Oral Silodosin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Recordati Oral Silodosin Product Portfolio
6.4.5 Recordati Recent Developments/Updates
6.5 Shanghai Huilun Pharmaceutical
6.5.1 Shanghai Huilun Pharmaceutical Corporation Information
6.5.2 Shanghai Huilun Pharmaceutical Description and Business Overview
6.5.3 Shanghai Huilun Pharmaceutical Oral Silodosin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai Huilun Pharmaceutical Oral Silodosin Product Portfolio
6.5.5 Shanghai Huilun Pharmaceutical Recent Developments/Updates
6.6 Hainan Wanwei Pharmaceutical
6.6.1 Hainan Wanwei Pharmaceutical Corporation Information
6.6.2 Hainan Wanwei Pharmaceutical Description and Business Overview
6.6.3 Hainan Wanwei Pharmaceutical Oral Silodosin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hainan Wanwei Pharmaceutical Oral Silodosin Product Portfolio
6.6.5 Hainan Wanwei Pharmaceutical Recent Developments/Updates
6.7 Kunming Jida Pharmaceutical
6.6.1 Kunming Jida Pharmaceutical Corporation Information
6.6.2 Kunming Jida Pharmaceutical Description and Business Overview
6.6.3 Kunming Jida Pharmaceutical Oral Silodosin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kunming Jida Pharmaceutical Oral Silodosin Product Portfolio
6.7.5 Kunming Jida Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Silodosin Industry Chain Analysis
7.2 Oral Silodosin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Silodosin Production Mode & Process
7.4 Oral Silodosin Sales and Marketing
7.4.1 Oral Silodosin Sales Channels
7.4.2 Oral Silodosin Distributors
7.5 Oral Silodosin Customers
8 Oral Silodosin Market Dynamics
8.1 Oral Silodosin Industry Trends
8.2 Oral Silodosin Market Drivers
8.3 Oral Silodosin Market Challenges
8.4 Oral Silodosin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Oral Silodosin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral Silodosin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oral Silodosin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral Silodosin Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Oral Silodosin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral Silodosin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral Silodosin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral Silodosin Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral Silodosin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Silodosin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Silodosin, Product Type & Application
Table 12. Global Key Manufacturers of Oral Silodosin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Silodosin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Silodosin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Silodosin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral Silodosin Sales by Region (2019-2024) & (K Units)
Table 18. Global Oral Silodosin Sales Market Share by Region (2019-2024)
Table 19. Global Oral Silodosin Sales by Region (2025-2030) & (K Units)
Table 20. Global Oral Silodosin Sales Market Share by Region (2025-2030)
Table 21. Global Oral Silodosin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral Silodosin Revenue Market Share by Region (2019-2024)
Table 23. Global Oral Silodosin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral Silodosin Revenue Market Share by Region (2025-2030)
Table 25. North America Oral Silodosin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral Silodosin Sales by Country (2019-2024) & (K Units)
Table 27. North America Oral Silodosin Sales by Country (2025-2030) & (K Units)
Table 28. North America Oral Silodosin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral Silodosin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral Silodosin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral Silodosin Sales by Country (2019-2024) & (K Units)
Table 32. Europe Oral Silodosin Sales by Country (2025-2030) & (K Units)
Table 33. Europe Oral Silodosin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral Silodosin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral Silodosin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral Silodosin Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Oral Silodosin Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Oral Silodosin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral Silodosin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral Silodosin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral Silodosin Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Oral Silodosin Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Oral Silodosin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Silodosin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oral Silodosin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oral Silodosin Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Oral Silodosin Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Oral Silodosin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Silodosin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral Silodosin Sales (K Units) by Type (2019-2024)
Table 51. Global Oral Silodosin Sales (K Units) by Type (2025-2030)
Table 52. Global Oral Silodosin Sales Market Share by Type (2019-2024)
Table 53. Global Oral Silodosin Sales Market Share by Type (2025-2030)
Table 54. Global Oral Silodosin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral Silodosin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral Silodosin Revenue Market Share by Type (2019-2024)
Table 57. Global Oral Silodosin Revenue Market Share by Type (2025-2030)
Table 58. Global Oral Silodosin Price (US$/Unit) by Type (2019-2024)
Table 59. Global Oral Silodosin Price (US$/Unit) by Type (2025-2030)
Table 60. Global Oral Silodosin Sales (K Units) by Application (2019-2024)
Table 61. Global Oral Silodosin Sales (K Units) by Application (2025-2030)
Table 62. Global Oral Silodosin Sales Market Share by Application (2019-2024)
Table 63. Global Oral Silodosin Sales Market Share by Application (2025-2030)
Table 64. Global Oral Silodosin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral Silodosin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral Silodosin Revenue Market Share by Application (2019-2024)
Table 67. Global Oral Silodosin Revenue Market Share by Application (2025-2030)
Table 68. Global Oral Silodosin Price (US$/Unit) by Application (2019-2024)
Table 69. Global Oral Silodosin Price (US$/Unit) by Application (2025-2030)
Table 70. Daiichi Sankyo Corporation Information
Table 71. Daiichi Sankyo Description and Business Overview
Table 72. Daiichi Sankyo Oral Silodosin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Daiichi Sankyo Oral Silodosin Product
Table 74. Daiichi Sankyo Recent Developments/Updates
Table 75. Lupin Pharmaceuticals Corporation Information
Table 76. Lupin Pharmaceuticals Description and Business Overview
Table 77. Lupin Pharmaceuticals Oral Silodosin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Lupin Pharmaceuticals Oral Silodosin Product
Table 79. Lupin Pharmaceuticals Recent Developments/Updates
Table 80. Aurobindo Pharma Corporation Information
Table 81. Aurobindo Pharma Description and Business Overview
Table 82. Aurobindo Pharma Oral Silodosin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Aurobindo Pharma Oral Silodosin Product
Table 84. Aurobindo Pharma Recent Developments/Updates
Table 85. Recordati Corporation Information
Table 86. Recordati Description and Business Overview
Table 87. Recordati Oral Silodosin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Recordati Oral Silodosin Product
Table 89. Recordati Recent Developments/Updates
Table 90. Shanghai Huilun Pharmaceutical Corporation Information
Table 91. Shanghai Huilun Pharmaceutical Description and Business Overview
Table 92. Shanghai Huilun Pharmaceutical Oral Silodosin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Shanghai Huilun Pharmaceutical Oral Silodosin Product
Table 94. Shanghai Huilun Pharmaceutical Recent Developments/Updates
Table 95. Hainan Wanwei Pharmaceutical Corporation Information
Table 96. Hainan Wanwei Pharmaceutical Description and Business Overview
Table 97. Hainan Wanwei Pharmaceutical Oral Silodosin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Hainan Wanwei Pharmaceutical Oral Silodosin Product
Table 99. Hainan Wanwei Pharmaceutical Recent Developments/Updates
Table 100. Kunming Jida Pharmaceutical Corporation Information
Table 101. Kunming Jida Pharmaceutical Description and Business Overview
Table 102. Kunming Jida Pharmaceutical Oral Silodosin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Kunming Jida Pharmaceutical Oral Silodosin Product
Table 104. Kunming Jida Pharmaceutical Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Oral Silodosin Distributors List
Table 108. Oral Silodosin Customers List
Table 109. Oral Silodosin Market Trends
Table 110. Oral Silodosin Market Drivers
Table 111. Oral Silodosin Market Challenges
Table 112. Oral Silodosin Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Silodosin
Figure 2. Global Oral Silodosin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral Silodosin Market Share by Type in 2023 & 2030
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Oral Silodosin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Oral Silodosin Market Share by Application in 2023 & 2030
Figure 8. Hospital and Clinic
Figure 9. Pharmacy
Figure 10. Global Oral Silodosin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Oral Silodosin Market Size (2019-2030) & (US$ Million)
Figure 12. Global Oral Silodosin Sales (2019-2030) & (K Units)
Figure 13. Global Oral Silodosin Average Price (US$/Unit) & (2019-2030)
Figure 14. Oral Silodosin Report Years Considered
Figure 15. Oral Silodosin Sales Share by Manufacturers in 2023
Figure 16. Global Oral Silodosin Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Oral Silodosin Players: Market Share by Revenue in 2023
Figure 18. Oral Silodosin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Oral Silodosin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Oral Silodosin Sales Market Share by Country (2019-2030)
Figure 21. North America Oral Silodosin Revenue Market Share by Country (2019-2030)
Figure 22. United States Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Oral Silodosin Sales Market Share by Country (2019-2030)
Figure 25. Europe Oral Silodosin Revenue Market Share by Country (2019-2030)
Figure 26. Germany Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Netherlands Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Oral Silodosin Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Oral Silodosin Revenue Market Share by Region (2019-2030)
Figure 33. China Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Oral Silodosin Sales Market Share by Country (2019-2030)
Figure 41. Latin America Oral Silodosin Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Oral Silodosin Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Oral Silodosin Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Oral Silodosin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Oral Silodosin by Type (2019-2030)
Figure 52. Global Revenue Market Share of Oral Silodosin by Type (2019-2030)
Figure 53. Global Oral Silodosin Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Oral Silodosin by Application (2019-2030)
Figure 55. Global Revenue Market Share of Oral Silodosin by Application (2019-2030)
Figure 56. Global Oral Silodosin Price (US$/Unit) by Application (2019-2030)
Figure 57. Oral Silodosin Value Chain
Figure 58. Oral Silodosin Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
